Alcon, Inc. (NYSE:ACL) has filed its Form 20-F annual report of foreign private issuer with the U.S. Securities and Exchange Commission (SEC). An electronic version of this annual filing is available for review in the Investors and Media section of the company’s web site or in the SEC’s EDGAR database at www.sec.gov.

Investors may obtain a printed copy of Alcon’s audited financial statements free of charge by contacting Alcon Investor Relations either by phone, e-mail or in writing at the address below.

Alcon Investor Relations6201 South Freeway, MC TA7-5Fort Worth, TX 76134Phone: 1-800-400-8599investor.relations@alconlabs.comwww.alcon.com

About Alcon

Alcon, Inc. is the world’s leading eye care company, with sales of approximately $7.2 billion in 2010. Alcon, which has been dedicated to the ophthalmic industry for 65 years, researches, develops, manufactures and markets pharmaceuticals, surgical equipment and devices, contacts lens solutions and other vision care products that treat diseases, disorders and other conditions of the eye. Alcon operates in 75 countries and sells products in 180 markets. For more information on Alcon, Inc., visit the Company’s web site at www.alcon.com.

Alcon (NYSE:ACL)
과거 데이터 주식 차트
부터 2월(2) 2025 으로 3월(3) 2025 Alcon 차트를 더 보려면 여기를 클릭.
Alcon (NYSE:ACL)
과거 데이터 주식 차트
부터 3월(3) 2024 으로 3월(3) 2025 Alcon 차트를 더 보려면 여기를 클릭.